embecta is a global diabetes care company that is leveraging its nearly 100-year legacy in insulin delivery to empower people with diabetes to live their best life through innovative solutions, partnerships and the passion of approximately 2,000 employees around the globe. For more information, visit embecta.com or follow our social channels on LinkedIn, Facebook, Instagram and Twitter.
Company profile
Ticker
EMBC
Exchange
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
Berra Newco, Inc.
SEC CIK
Corporate docs
Subsidiaries
Becton Dickinson Penel Limited • embecta Arabia Limited Co. • embecta Argentina S.R.L. • embecta Australia Pty Ltd • embecta Austria GmbH • embecta Belgium BV • embecta Brasil Ltda. • Embecta Canada Co. • embecta Colombia S.A.S. • embecta Croatia Ltd. ...
IRS number
871583942
EMBC stock data
Latest filings (excl ownership)
8-K
Entry into a Material Definitive Agreement
28 Mar 24
8-K
Submission of Matters to a Vote of Security Holders
9 Feb 24
10-Q
2024 Q1
Quarterly report
9 Feb 24
8-K
Embecta Corp. Reports First Quarter Fiscal 2024 Financial Results
9 Feb 24
ARS
2023 FY
Annual report to shareholders
19 Dec 23
DEFA14A
Additional proxy soliciting materials
19 Dec 23
DEF 14A
Definitive proxy
19 Dec 23
10-K
2023 FY
Annual report
29 Nov 23
8-K
Embecta Corp. Reports Fiscal 2023 Fourth Quarter and Full Year Financial Results and Provides Initial Fiscal 2024 Financial Guidance
21 Nov 23
Transcripts
EMBC
Earnings call transcript
2024 Q1
9 Feb 24
EMBC
Earnings call transcript
2023 Q4
21 Nov 23
EMBC
Earnings call transcript
2023 Q3
8 Aug 23
EMBC
Earnings call transcript
2023 Q2
12 May 23
EMBC
Earnings call transcript
2023 Q1
14 Feb 23
EMBC
Earnings call transcript
2022 Q4
20 Dec 22
EMBC
Earnings call transcript
2022 Q3
15 Aug 22
EMBC
Earnings call transcript
2022 Q2
13 May 22
Latest ownership filings
3/A
Christopher R Reidy
23 Apr 24
3/A
David F Melcher
23 Apr 24
4
Devdatt Kurdikar
8 Apr 24
SC 13G/A
T. Rowe Price Investment Management, Inc.
14 Feb 24
SC 13G/A
VANGUARD GROUP INC
13 Feb 24
4
Devdatt Kurdikar
13 Feb 24
4
David F Melcher
12 Feb 24
SC 13G
AMERICAN CENTURY INVESTMENT MANAGEMENT INC
12 Feb 24
4
David Albritton
9 Feb 24
4
Carrie L Anderson
9 Feb 24
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Sep 23 | Sep 22 | |
---|---|---|---|
Revenue | |||
Cost of revenue | |||
Operating income | |||
Operating margin | |||
Net income | |||
Net profit margin | |||
Cash on hand | |||
Change in cash | |||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 326.50 mm | 326.50 mm | 326.50 mm | 326.50 mm | 326.50 mm | 326.50 mm |
Cash burn (monthly) | (no burn) | 366.67 k | (no burn) | (no burn) | (no burn) | (no burn) |
Cash used (since last report) | n/a | 2.51 mm | n/a | n/a | n/a | n/a |
Cash remaining | n/a | 323.99 mm | n/a | n/a | n/a | n/a |
Runway (months of cash) | n/a | 883.6 | n/a | n/a | n/a | n/a |
Institutional ownership, Q3 2023
13F holders | Current |
---|---|
Total holders | 360 |
Opened positions | 40 |
Closed positions | 58 |
Increased positions | 80 |
Reduced positions | 129 |
13F shares | Current |
---|---|
Total value | 839.09 bn |
Total shares | 65.09 mm |
Total puts | 202.76 k |
Total calls | 223.26 k |
Total put/call ratio | 0.9 |
Largest owners | Shares | Value |
---|---|---|
BLK Blackrock | 8.92 mm | $134.29 bn |
Vanguard | 7.01 mm | $105.43 bn |
American Century Investment Management | 5.84 mm | $0.00 |
American Century Companies | 4.43 mm | $66.74 bn |
Millennium Management | 3.35 mm | $50.43 bn |
Integrated Core Strategies | 3.17 mm | $57.36 mm |
Yacktman Asset Management | 2.65 mm | $39.90 bn |
River Road Asset Management | 2.61 mm | $39.33 bn |
STT State Street | 2.48 mm | $37.26 bn |
FMR | 2.35 mm | $35.30 bn |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
4 Apr 24 | Devdatt Kurdikar | Common Stock | Payment of exercise | Dispose F | No | No | 12.78 | 4,535 | 57.96 k | 388,005.2 |
12 Feb 24 | Melcher David F | Common Stock | Buy | Acquire P | No | No | 16.25 | 2,000 | 32.50 k | 45,080.275 |
11 Feb 24 | Devdatt Kurdikar | Common Stock | Payment of exercise | Dispose F | No | No | 16.26 | 17,165 | 279.10 k | 389,940.3 |
7 Feb 24 | Milton Mayo Morris | Common Stock | Grant | Acquire A | No | No | 0 | 11,455 | 0.00 | 24,845.307 |
7 Feb 24 | Christopher R Reidy | Common Stock | Grant | Acquire A | No | No | 0 | 11,455 | 0.00 | 32,383.902 |
Press releases
embecta-sponsored Educational Symposium and Abstracts at ATTD Highlight Role of Insulin Pumps in the Management of Type 2 Diabetes
6 Mar 24
Embecta Corp. Reports First Quarter Fiscal 2024 Financial Results
9 Feb 24
embecta Announces Quarterly Cash Dividend
9 Feb 24
embecta to Participate in the 11th Annual BTIG MedTech Conference
7 Feb 24